NCT05331846

Brief Summary

Our study aims to determine the effect of breast milk odor on pain and stress in the application of endotracheal aspiration in newborns hospitalized in the Neonatal Intensive Care Unit. The research is planned experimentally with a pretest posttest randomized control group. The research will be carried out in Şanlıurfa Training and Research Hospital Neonatal Intensive Care Unit between March-December 2022. The population of the study will consist of patients aged 30-28 days who were hospitalized in the Şanlıurfa Training and Research Hospital Neonatal Intensive Care Unit between March-December 2022 and received mechanical ventilation treatment. The research sample; Babies of families who are hospitalized on the dates specified with the probability sampling method and meet the research criteria and volunteer to participate in the research will be formed. Questionnaire Form, Neonatal Pain and Stress Assessment Scale, and Follow-up Form will be used to collect research data. The scent of breast milk will be used as an intervention tool in the research.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
88

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 19, 2022

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

April 10, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 18, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 27, 2022

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 19, 2023

Completed
Last Updated

March 8, 2024

Status Verified

March 1, 2024

Enrollment Period

5 months

First QC Date

April 10, 2022

Last Update Submit

March 6, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • ALPS Neo Neonatal Pain and Stress Rating Scale

    In 2014, the "Newborn Pain and Stress Rating Scale" was developed based on the individualized developmental care of the newborn in order to evaluate pain and stress in premature and term newborns. In 2017, this scale was adapted to Turkish and validity and reliability studies were conducted. ALPS Neo "Newborn Pain and Stress Assessment Scale" is a 3-point Likert-type scale consisting of 5 items, including "facial expression, breathing pattern, tone of extremities, hand/foot activities and activity level" of the newborn, and measurements are made by observation. As the scores obtained increase, pain and stress increase in the newborn. As a result of the evaluation, "3-5 points indicate the presence of mild pain and stress, and more than 5 points indicate the presence of severe pain and stress".

    9 MONTHS

Study Arms (2)

SMELL OF BREAST MILK

EXPERIMENTAL

the smell of breast milk will reduce pain and stress

Behavioral: the smell of breast milk

control

NO INTERVENTION

pain and stress will not decrease

Interventions

Smell of breast milk during endotracheal aspiration will reduce pain and stress

SMELL OF BREAST MILK

Eligibility Criteria

Age1 Day - 28 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Being a term newborn,
  • to be between 0-28 days,
  • Receiving mechanical ventilation support,
  • Not taking opioids or sedatives 4 hours before the procedure.

You may not qualify if:

  • not be between 0-28 days,
  • Not receiving mechanical ventilation support,
  • Taking opioids or sedatives 4 hours before the procedure.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ataturk University Nursing of Faculty

Erzurum, Center, 25240, Turkey (Türkiye)

Location

Study Officials

  • ARZU SARIALİOĞLU, PHD

    Ataturk University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 10, 2022

First Posted

April 18, 2022

Study Start

March 19, 2022

Primary Completion

August 27, 2022

Study Completion

December 19, 2023

Last Updated

March 8, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

THE ARTICLE IS INTENDED TO BE SHARED AFTER IT IS PUBLISHED

Locations